Earnings · China A-shares
Shanghai Labway Clinical Laboratory Co., Ltd. Class A (301060) earnings
Shanghai Labway Clinical Laboratory Co., Ltd. Class A published its Q3 report on 2026-10-26: net profit +10739.06% year on year, +271.70% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved -7.67% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-26
- Period end
- 2026-09-30
- Net profit YoY
- +10739.06%
- Excl. one-offs YoY
- +271.70%
- Net profit QoQ
- -72.09%
- Result
- Great
- Quality score
- 82
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -9.33% | — |
| 3 days | -7.67% | — |
| 7 days | -8.04% | — |
| 14 days | -10.07% | — |
Report history
Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 2 of 6 reports (average -0.69%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-27 | ¥71.04M | +10739.06% | +271.70% | -19.06% | 0.18 | 4.54% | -7.67% | — | — |
| 2026 interim report | 2026-08-22 | ¥63.59M | +1199.63% | +314.47% | -22.09% | 0.16 | 4.02% | -3.04% | +0.26% | +7.18% |
| 2026 Q1 report | 2026-04-29 | ¥36.91M | +556.80% | +182.34% | -18.16% | 0.09 | 2.36% | +10.33% | -9.27% | -10.22% |
| 2025 annual report | 2026-04-29 | -¥30.75M | +71.90% | +59.16% | -16.88% | -0.08 | -1.92% | +10.33% | -9.27% | -10.22% |
| 2025 Q3 report | 2025-10-28 | -¥667.74K | +98.35% | +84.79% | -16.51% | 0.00 | -0.04% | -0.84% | +9.59% | +12.96% |
| 2025 interim report | 2025-08-26 | -¥5.78M | -137.08% | — | -14.50% | -0.01 | -0.35% | -5.76% | -14.07% | -15.75% |
| 2025 Q1 report | 2025-04-28 | -¥8.08M | -854.01% | — | -19.60% | -0.02 | -0.49% | +2.82% | +8.34% | +5.10% |
| 2024 annual report | 2025-04-28 | -¥109.44M | +22.71% | +28.18% | +4.05% | -0.27 | -6.37% | +2.82% | +8.34% | +5.10% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.